Article | November 19, 2021

Cell Culture Process Development For AAV Vector Production In Suspension Cells

Source: Cytiva
iStock-823447656-vector-viral-lab-AAV-cell-development

Recombinant adeno-associated virus (rAAV) vectors are common gene transfer vehicles in gene therapy research and in developing potential new therapies. To support the growing need for high-quality vector, scalable production processes are needed.

In the first set of experiments, we describe how to adapt adherent HEK293T/HEK293 cells to suspension culture in a new cell culture medium, evaluating cell growth by population doubling time, morphology, and viability. And we describe how to use a Design of Experiments (DoE) methodology to evaluate several parameters that could affect productivity.

In the second set of experiments, we describe how to optimize the transient transfection, which forms the basis for a scalable AAV production process in single-use bioreactors. We measured viral particles/L, viral genomes/L, and percentage full capsids.

Read this article to see the in-depth analysis.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Drug Discovery Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: